HIGHLIGHTS
- who: Xiaosha Wen and collaborators from the Laboratory of Microenvironment Responsive Drug Research, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, China have published the research: Circulating Tumor DNAu2014A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques, in the Journal: Cancers
- what: CtDNA is an ideal tumor marker which can effectively reflect the dynamic changes in early tumor screening, diagnosis, tumor molecular subtyping profiles, prognosis, recurrence monitoring, and medication guidance.
- how: The results showed that most of the DNA in the cerebrospinal fluid was ctDNA. Third a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.